Results 71 to 80 of about 39,521 (156)

Progressive Proximal Muscle Weakness Due to a 51 CAG Repeat Expansion in Exon 1 of the Androgen Receptor Gene: A Case Report of Kennedy Disease. [PDF]

Am J Case Rep
Thi Tuong Vi N, Huu Thanh N, Thi Bien D, Hong Quan N.   +3 more
europepmc   +1 more source

Hirayama disease - A case report and literature review. [PDF]

Surg Neurol Int
Danushka N, Jayasinghe R, Biseka S, Jeyaratnam Y, Attanayaka D.   +4 more
europepmc   +1 more source

Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy. [PDF]

JPRAS Open
Adıgüzel İF, Yenidünya MK.
europepmc   +1 more source

Clinicodemographic and Genetic Profile of Children with Spinal Muscular Atrophy in Kerala, India: A Single-Center Experience. [PDF]

Ann Indian Acad Neurol
Hafsa, Mohanlal S, Mubeena PM, Balaji A, Pramod S, Kumar S, Pachat D.   +6 more
europepmc   +1 more source

[Spinal muscular atrophy: Clinical and genetic aspects, and therapeutic alternatives]. [PDF]

Rev Med Inst Mex Seguro Soc
González-Morales IJ, Olivera-Bernal GC, León-González C DA, Rosas-Vargas H.   +3 more
europepmc   +1 more source

A type IV spinal muscular atrophy with gastrocnemius pseudohypertrophy caused by SMN1 deletion: a case report and literature review. [PDF]

BMC Neurol
Xi H, He W, Jiang H, Xie W, Yang Y, Yang Y, Diao K, Yang W, Li H.   +8 more
europepmc   +1 more source

Haloperidol induces neuroprotection and enhances neuromuscular function in both murine and human models of spinal muscular atrophy. [PDF]

Exp Mol Med
Menduti G, Perez-Gomez R, Berenger-Currias N, Ruatti C, Espinosa-Espinosa J, Januel C, Konieczny P, Artero R, Martinat C, Boido M.   +9 more
europepmc   +1 more source

Using wearable sensors during the timed up and go and 6-minute walk test in Spinal Bulbar Muscular Atrophy. [PDF]

PLOS Digit Health
Doreswamy K, Roberts H, Kokkinis A, Joe G, Alqahtani A, Grunseich C, Jain M.   +6 more
europepmc   +1 more source

Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts. [PDF]

FASEB J
Vrettou S, Zetzsche S, Wirth B.
europepmc   +1 more source

Patient reported outcome measures in spinal muscular atrophy and duchenne muscular dystrophy: review of instruments and their inclusion in clinical and regulatory processes. [PDF]

Neurol Sci
Malandrini F, Spataro C, Meregaglia M, Sansone V, D'amico A, Scopinaro A, Ciani O.   +6 more
europepmc   +1 more source